£37.67 (exc VAT)
£45.20 (inc VAT)
For the active immunisation of calves from 12 weeks of age to reduce virus excretion and the clinical signs caused by PI3 virus; virus excretion caused by BRSV infection, reduce virus excretion and the severity of leucopenia induced by BVDV type 1 infection.
Onset of immunity: 3 weeks after vaccination.
Duration of immunity: 6 months (demonstrated by challenge studies) after vaccination for BRSV and BVDV Type 1. Duration of immunity has not been established for PI3. Efficacy has not been demonstrated against BVDV Type 2 strains.
Rispoval 3 is a freeze dried fraction containing modified live PI3 (Parainfluenza 3) virus, strain RLB103 and modified live BRSV (Bovine Respiratory Syncytial virus) strain 375, supplied with a liquid fraction containing inactivated BVDV (Bovine Viral Diarrhoea Virus) type 1, strains 5960 (cytopathic) and 6309 (non-cytopathic) (to induce a SN titre in guinea pigs of at least 3.0 log2) and the adjuvant Alhydrogel 2% 0.8ml (equivalent to 24.36mg of aluminium hydroxide).
Legal Category: POM-V
Dosage
The dose is 4ml. Reconstitute the vaccine by mixing the freeze-dried component with the liquid fraction and shake well. Administer the reconstituted vaccine by the intramuscular route.
Vaccination Programme
For cattle from 12 weeks of age two doses 3-4 weeks apart. Animals should preferably be vaccinated at least 3 weeks before a period of stress or high infection risk like re-grouping, transport of animals or the start of the autumn season.
Animals should preferably be vaccinated at least 3 weeks before a period of stress or high infection risk like re-grouping, transport of animals or the start of the autumn season. If ongoing protection against BRSV and BVDV Type 1 is required, then animals should be re-vaccinated after 6 months.
Withdrawal Period: Zero days
Gestation Period, lactation and fertility: Do not use during pregnancy and lactation.
Contra Indications
Do not use in unhealthy animals.
The administration of the vaccine can lead to a transient and mild hyperthermia which can last for 2 days and to a transient, minor local inflammation reaction of up to 0.5cm which disappears within 15 days. No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product.
Package quantities: 5 dose
For the most up to date information about this product please look up the Summary of Product Characteristics (SPC) on the VMD webpage Product Information Database.
